1/3

Comprehensive Drug-Resistant Tuberculosis (DR-TB) Treatment in Kandahar

: In the southern region of Afghanistan, MSF provides treatment for Multi Drug-Resistant Tuberculosis (MDR-TB) in Kandahar Province. Through a unique patient-centred model of care, MSF has been collaborating with the Ministry of Public Health to diagnose and treat MDR-TB patients. Due to the needs in the province, MSF also started a nutrition component in the project in April 2022 and currently runs a 40-bed inpatient therapeutic feeding centre (ITFC) and an ambulatory therapeutic feeding centre (ATFC) for children under five years.

MSBSTO42566

Linked assets

Drug-Resistant Tuberculosis (DR-TB) Treatment in Kandahar

2023

Conceptually similar

Treating Drug Resistant TB in Kandahar

Diagnose and Treatment for Patients with Drug-Resistant Tuberculosis (DR-TB) | Kandahar TB Hospital

Challenges in accessing TB treatment in Afghanistan

Malnutrition treatment in Sokoto, Northwest Nigeria

Drug-resistant TB (DR-TB) Colony 3. Donetsk Ukraine

Ambulatory care for DR-TB patients in Sierra Leone'

Belarus: Improving outpatient drug resistant tuberculosis treatment.

Herat Earthquake

MSF in Maiduguri

Joanne Liu visits ITFC in Maiduguri, Nigeria

Paediatric TB Care in Tajikistan

Treating drug resistant TB in the Western Cape, South Africa

An “MSF emergency malnutrition response” in September 2021 has since evolved into a long-term project to address the recurrent nutritional crises in Chad’s Hadjer Lamis region.